(1S,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione

Catalog No. :
ACCRHS504
CAS No. :
1889291-47-7
Molecular Formula :
C11H8BrNO4
Molecular Weight :
298.09

IUPAC Name:(1S,3R)-5-bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione

(1S,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg99%$221.00Login to see priceIn stockInquiry
250mg99%$529.00Login to see priceIn stockInquiry
1g99%$2065.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione
IUPAC Name(1S,3R)-5-bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione
Molecular FormulaC11H8BrNO4
Molecular Weight298.09
SMILESO=C1NC(=O)[C@@]2(C[C@@H](O)C3=CC(Br)=CC=C32)O1
InChI KeyZFGQJQXMVHWYRI-KCJUWKMLSA-N
Synonym(1S,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione;Spiro[1H-indene-1,5'-oxazolidine]-2',4'-dione, 5-bromo-2,3-dihydro-3-hydroxy-, (1S,3R)-;(1S,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione - [B88617]
CAS No.1889291-47-7

Safety Data

Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCRHS504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCRHS504 route product structure diagram
    ACCRHS5041889291-47-7 In Stock
Inquiry

2. ACCRHS504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCRHS504 route product structure diagram
    ACCRHS5041889291-47-7 In Stock
Inquiry

Comments (0)